Decreased placental glypican expression is associated with human fetal growth restriction.
Fetal growth
Glypican
Heparan sulphate
Proteoglycans
Restriction
Journal
Placenta
ISSN: 1532-3102
Titre abrégé: Placenta
Pays: Netherlands
ID NLM: 8006349
Informations de publication
Date de publication:
15 01 2019
15 01 2019
Historique:
received:
21
12
2016
revised:
05
12
2018
accepted:
17
12
2018
entrez:
27
2
2019
pubmed:
26
2
2019
medline:
13
3
2020
Statut:
ppublish
Résumé
Placental mediated fetal growth restriction (FGR) is a leading cause of perinatal morbidity and mortality. Heparan sulphate proteoglycans (HSPG) are highly expressed in placentae and regulate haemostasis. We hypothesise that altered expression of HSPGs, glypicans (GPC) may contribute to the development of FGR and small-for-gestational-age (SGA). GPC expression was determined in first-trimester chorionic villous samples collected from women with later SGA pregnancies and in placentae from third-trimester FGR and gestation-matched uncomplicated pregnancies. The expression of both GPC1 and GPC3 were significantly reduced in first-trimester SGA as well as in the third-trimester FGR placentae compared to controls. This is the first study to report a relationship between altered placental GPC expression and subsequent development of SGA/FGR.
Identifiants
pubmed: 30803713
pii: S0143-4004(18)31204-9
doi: 10.1016/j.placenta.2018.12.007
pii:
doi:
Substances chimiques
Glypicans
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
6-9Informations de copyright
Copyright © 2018. Published by Elsevier Ltd.